Research Priorities - Cancer
  • Article
  • Jun 25 2024

New UK research reveals concerning declines in cervical cancer screening rates among women in the U.S. during the COVID-19 pandemic.

  • Article
  • Jun 14 2024

A report from the UK Markey Cancer Center’s Kentucky Cancer Registry shows that Kentucky has higher rates of childhood cancer compared to the national average, with Appalachian counties experiencing an even greater burden.

  • Article
  • Jun 12 2024

UK Research welcomed Monica Bertagnolli, M.D., the NIH director, to the Healthy Kentucky Research Building — a space dedicated to enabling multidisciplinary teams to find solutions to reduce the health disparities greatly impacting Kentucky.

  • Article
  • Jun 6 2024

Markey physicians and scientists shared their latest findings at the American Society of Clinical Oncology's (ASCO) annual meeting in Chicago May 31 to June 4.

  • Article
  • May 13 2024

The 14th annual event showcased the latest advancements in cancer research from UK faculty members, students and staff across these many disciplines.

  • Article
  • May 6 2024

Researchers at the College of Nursing and DanceBlue Kentucky Children’s Hospital Hematology/Oncology Clinic found that receiving financial and legal navigation services improves financial toxicity and quality of life for patients and caregivers.

  • Article
  • May 3 2024

Jill Kolesar was appointed as chair of the steering committee for the Oncology Research Information Exchange Network® (ORIEN), an alliance of 19 cancer centers across the U.S.

  • Article
  • Apr 26 2024

Jin-Ming Yang was recently awarded a five-year grant from the National Cancer Institute to support research focused on improving the effectiveness of immunotherapy treatment for melanoma.

  • Article
  • Mar 12 2024

A recent University of Kentucky Markey Cancer Center study published in PNAS uncovers a critical pathway involved in immune evasion by breast cancer cells.

  • Article
  • Feb 23 2024

A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.